Drug Shortage Report for MYLAN-AMLODIPINE/ATORVASTATIN
| Report ID | 217876 |
| Drug Identification Number | 02362821 |
| Brand name | MYLAN-AMLODIPINE/ATORVASTATIN |
| Common or Proper name | ATORVASTATIN AMLODIPINE |
| Company Name | MYLAN PHARMACEUTICALS ULC |
| Market Status | MARKETED |
| Active Ingredient(s) | ATORVASTATIN AMLODIPINE |
| Strength(s) | 80MG 10MG |
| Dosage form(s) | TABLET |
| Route of administration | ORAL ORAL |
| Packaging size | 1x90 BTL |
| ATC code | C10BX |
| ATC description | LIPID MODIFYING AGENTS, COMBINATIONS |
| Reason for shortage | Disruption of the manufacture of the drug. |
| Anticipated start date | |
| Actual start date | 2023-08-07 |
| Estimated end date | 2024-07-09 |
| Actual end date | |
| Shortage status | Actual shortage |
| Updated date | 2024-04-16 |
| Company comments | |
| Health Canada comments | |
| Tier 3 Status | No |
| Contact Address | 85 ADVANCE ROAD ETOBICOKE, ONTARIO CANADA M8Z 2S6 |
| Company contact information | Mylan Pharmaceuticals ULC, 85 Advance Road, Etobicoke, ON, M8Z 2S6 |
Version History
Click on "Compare" below to view the full report history and compare to other versions.
| Version Number | Date Updated | Language | |
|---|---|---|---|
| v6 | 2024-04-16 | French | Compare |
| v5 | 2024-04-16 | English | Compare |
| v4 | 2024-02-28 | French | Compare |
| v3 | 2024-02-28 | English | Compare |
| v2 | 2024-01-30 | French | Compare |
| v1 | 2024-01-30 | English | Compare |
Showing 1 to 6 of 6